Literature DB >> 15111530

Reduced coronary artery and abdominal aortic calcification in Hispanics with type 2 diabetes.

Peter D Reaven1, Jerome Sacks.   

Abstract

OBJECTIVE: To compare lifestyle factors, cardiovascular risk factors, and coronary artery calcium (CAC) and abdominal aortic calcium (AAC) levels in Hispanic and non-Hispanic white (NHW) individuals with type 2 diabetes. RESEARCH DESIGN AND METHODS: We recently demonstrated in a small group of nonreferred, healthy, nondiabetic subjects that CAC was reduced in Hispanics compared with NHWs, despite a worse cardiovascular risk factor profile. In this study, we evaluated whether this ethnic disparity in vascular calcification was present in individuals with type 2 diabetes and in several different arterial beds. Hispanic and NHW subjects (n = 245) with type 2 diabetes were evaluated for cardiovascular risk factors using questionnaires and assays of plasma biomarkers. CAC and AAC were measured by electron-beam computer-assisted tomography.
RESULTS: Although Hispanics were slightly younger than NHWs, other standard risk factors and novel cardiovascular risk factors, including plasminogen activator-1 and fibrinogen levels, were similar between the groups. Despite the similar risk factor profile, the prevalence of cardiovascular disease (CVD) and mean and median levels of CAC and AAC were lower in Hispanics. Furthermore, the distribution of these calcium scores differed from that of NHWs (P < 0.05), with significantly fewer Hispanic subjects having high CAC or AAC scores. These differences were not explained by differences in CVD prevalence or any measured lifestyle or risk factor.
CONCLUSIONS: Hispanics with type 2 diabetes have reduced CAC and AAC levels compared with NHW subjects, suggesting a reduction in the overall burden of vascular calcification and atherosclerosis. These data are consistent with the notion that Hispanics are protected against the development of CVD.

Entities:  

Mesh:

Year:  2004        PMID: 15111530     DOI: 10.2337/diacare.27.5.1115

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  10 in total

1.  Relationship between CT anthropometric measurements, adipokines and abdominal aortic calcification.

Authors:  Jonathan Golledge; Rumal Jayalath; Lisa Oliver; Adam Parr; Leon Schurgers; Paula Clancy
Journal:  Atherosclerosis       Date:  2007-08-06       Impact factor: 5.162

2.  Vascular calcification in patients with large-vessel vasculitis compared to patients with hyperlipidemia.

Authors:  Shubhasree Banerjee; Mohammadhadi Bagheri; Veit Sandfort; Mark A Ahlman; Ashkan A Malayeri; David A Bluemke; Jianhua Yao; Peter C Grayson
Journal:  Semin Arthritis Rheum       Date:  2018-09-17       Impact factor: 5.532

3.  A Link Between Hypoglycemia and Progression of Atherosclerosis in the Veterans Affairs Diabetes Trial (VADT).

Authors:  Aramesh Saremi; Gideon D Bahn; Peter D Reaven
Journal:  Diabetes Care       Date:  2016-01-19       Impact factor: 19.112

4.  The effect of intensive glucose lowering therapy among major racial/ethnic groups in the Veterans Affairs Diabetes Trial.

Authors:  Aramesh Saremi; Dawn C Schwenke; Gideon Bahn; Ling Ge; Nicholas Emanuele; Peter D Reaven
Journal:  Metabolism       Date:  2014-10-17       Impact factor: 8.694

5.  Risk Factors for the Development and Progression of Thoracic Aorta Calcification: The Multi-Ethnic Study of Atherosclerosis.

Authors:  George Youssef; Mengye Guo; Robyn L McClelland; David M Shavelle; Khurram Nasir; Juan Rivera; J Jeffrey Carr; Nathan D Wong; Matthew J Budoff
Journal:  Acad Radiol       Date:  2015-09-26       Impact factor: 3.173

6.  Coronary artery and abdominal aortic calcification are associated with cardiovascular disease in type 2 diabetes.

Authors:  P D Reaven; J Sacks
Journal:  Diabetologia       Date:  2005-02-02       Impact factor: 10.122

7.  Rates and determinants of coronary and abdominal aortic artery calcium progression in the Veterans Affairs Diabetes Trial (VADT).

Authors:  Aramesh Saremi; Thomas E Moritz; Robert J Anderson; Carlos Abraira; William C Duckworth; Peter D Reaven
Journal:  Diabetes Care       Date:  2010-08-31       Impact factor: 19.112

8.  Role of homocysteine in aortic calcification and osteogenic cell differentiation.

Authors:  Ann Van Campenhout; Corey S Moran; Adam Parr; Paula Clancy; Catherine Rush; Hieronim Jakubowski; Jonathan Golledge
Journal:  Atherosclerosis       Date:  2008-05-28       Impact factor: 5.162

9.  Trends in relative mortality between Hispanic and non-Hispanic whites initiating dialysis: a retrospective study of the US Renal Data System.

Authors:  Cristina M Arce; Benjamin A Goldstein; Aya A Mitani; Wolfgang C Winkelmayer
Journal:  Am J Kidney Dis       Date:  2013-05-04       Impact factor: 8.860

10.  Intensive glucose-lowering therapy reduces cardiovascular disease events in veterans affairs diabetes trial participants with lower calcified coronary atherosclerosis.

Authors:  Peter D Reaven; Thomas E Moritz; Dawn C Schwenke; Robert J Anderson; Michael Criqui; Robert Detrano; Nicholas Emanuele; Moti Kayshap; Jennifer Marks; Sunder Mudaliar; R Harsha Rao; Jayendra H Shah; Steven Goldman; Domenic J Reda; Madeline McCarren; Carlos Abraira; William Duckworth
Journal:  Diabetes       Date:  2009-08-03       Impact factor: 9.461

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.